Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 12/20 | 0.46 |
| ▸ | LIPG | Q9Y5X9 | 12/20 | 0.46 |
| ▸ | DGAT1 | O75907 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CA9 | Q16790 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA3 | P07451 | 1/20 | 0.39 |
| ▸ | CA4 | P22748 | 1/20 | 0.39 |
| ▸ | CA6 | P23280 | 1/20 | 0.39 |
| ▸ | CA5A | P35218 | 1/20 | 0.39 |
| ▸ | CA7 | P43166 | 1/20 | 0.39 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.39 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.39 |
| ▸ | F11 | P03951 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2099623 | 0.81 | LPL (0.46) | LPLLIPGDGAT1CA1CA2 | |
| SCHEMBL29483036 | 0.81 | LPL (0.46) | LPLLIPGDGAT1CA1CA2 | |
| SCHEMBL20068614 | 0.81 | DGAT1 (0.56) | LPLLIPGDGAT1CA1CA2 | |
| SCHEMBL31219310 | 0.79 | LPL (0.47) | LPLLIPGDGAT1CA1CA2 | |
| SCHEMBL42112 | 0.79 | LPL (0.47) | LPLLIPGDGAT1CA1CA2 | |
| SCHEMBL1602392 | 0.78 | LPL (0.46) | LPLLIPGDGAT1CA1CA2 | |
| SCHEMBL16278109 | 0.78 | LPL (0.46) | LPLLIPGDGAT1CA1CA2 | |
| SCHEMBL17787570 | 0.78 | LPL (0.46) | LPLLIPGDGAT1CA1CA2 | |
| SCHEMBL506215 | 0.78 | DGAT1 (0.47) | LPLLIPGDGAT1CA1CA2 | |
| SCHEMBL29516651 | 0.78 | LPL (0.46) | LPLLIPGDGAT1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2012027234-A1 | FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN | SCHERING CORPORATION (US) | 2012-03-01 | — | — | WO | disclosed |
| EP-2233490-A1 | NOVEL BORON COMPOUND, METHOD FOR PRODUCING THE SAME, AND FUNCTIONAL ELECTRONIC DEVICE USING THE SAME | Kyoto University (JP) | 2010-09-29 | — | — | EP | disclosed |